Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.
Saved in:
| Title: | Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects. |
|---|---|
| Authors: | Gillon JY; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Dennison J; Hammersmith Medicines Research Ltd, London, UK., van den Berg F; Hammersmith Medicines Research Ltd, London, UK.; Invicro, Burlington Danes Building, Imperial College London, Hammersmith Hospital, London, UK., Delhomme S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Dequatre Cheeseman K; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Peña Rossi C; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Strub Wourgaft N; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Specht S; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Pedrique B; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Monnot F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland., Skrabs S; Bayer AG, Wuppertal, Germany., Rodriguez ML; Bayer AG, Wuppertal, Germany., Stass H; Bayer AG, Wuppertal, Germany. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Oct; Vol. 87 (10), pp. 3949-3960. Date of Electronic Publication: 2021 Mar 31. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
